image credit: Freepik

COVID-19 vaccines are effective in 94% of cancer patients, shows study

July 1, 2021


In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.

Among the 131 patients studied, 94% developed antibodies to the coronavirus. Seven high-risk patients did not.

Read More on Medical News